Búsqueda | Portal de Búsqueda de la BVS Ecuador

1.

PRMT5 supports multiple oncogenic pathways in mantle cell lymphoma.

Sloan, Shelby L; Brown, Fiona; Long, Mackenzie; Weigel, Christoph; Koirala, Shirsha; Chung, Ji-Hyun; Pray, Betsy; Villagomez, Lynda; Hinterschied, Claire; Sircar, Anuvrat; Helmig-Mason, JoBeth; Prouty, Alexander; Brooks, Eric; Youssef, Youssef; Hanel, Walter; Parekh, Samir; Chan, Wing Keung; Chen, Zhengming; Lapalombella, Rosa; Sehgal, Lalit; Vaddi, Kris; Scherle, Peggy; Chen-Kiang, Selina; Di Liberto, Maurizio; Elemento, Olivier; Meydan, Cem; Foox, Jonathan; Butler, Daniel; Mason, Christopher E; Baiocchi, Robert A; Alinari, Lapo.

Blood ; 142(10): 887-902, 2023 09 07.

Artículo en Inglés | MEDLINE | ID: mdl-37267517

2.

Prognostic relevance of circulating lymphoma cells at diagnosis in newly diagnosed follicular lymphoma patients.

Annunzio, Kaitlin; Bhatta, Subodh; Hanel, Walter; Zhao, Qiuhong; Owen, Mackenzie; Rosen, Havi; Voorhees, Timothy J; Bond, David A; Sawalha, Yazeed; Sigmund, Audrey M; Alinari, Lapo; Baiocchi, Robert A; Maddocks, Kami J; Jones, Daniel; Christian, Beth; Epperla, Narendranath.

Hematol Oncol ; 42(3): e3278, 2024 May.

Artículo en Inglés | MEDLINE | ID: mdl-38726682

3.

Protein arginine methyltransferase 5 represses tumor suppressor miRNAs that down-regulate CYCLIN D1 and c-MYC expression in aggressive B-cell lymphoma.

Karkhanis, Vrajesh; Alinari, Lapo; Ozer, Hatice Gulcin; Chung, Jihyun; Zhang, Xiaoli; Sif, Saïd; Baiocchi, Robert A.

J Biol Chem ; 295(5): 1165-1180, 2020 01 31.

Artículo en Inglés | MEDLINE | ID: mdl-31822509

4.

Transducin ß-like protein 1 controls multiple oncogenic networks in diffuse large B-cell lymphoma.

Youssef, Youssef; Karkhanis, Vrajesh; Chan, Wing Keung; Jeney, Frankie; Canella, Alessandro; Zhang, Xiaoli; Sloan, Shelby; Prouty, Alexander; Helmig-Mason, JoBeth; Tsyba, Liudmyla; Hanel, Walter; Zheng, Xuguang; Zhang, Pu; Chung, Ji-Hyun; Lucas, David M; Kauffman, Zachary; Larkin, Karilyn; Strohecker, Anne M; Ozer, Hatice G; Lapalombella, Rosa; Zhou, Hui; Xu-Monette, Zijun Y; Young, Ken H; Han, Ruolan; Nurmemmedov, Elmar; Nuovo, Gerard; Maddocks, Kami; Byrd, John C; Baiocchi, Robert A; Alinari, Lapo.

Haematologica ; 106(11): 2927-2939, 2021 11 01.

Artículo en Inglés | MEDLINE | ID: mdl-33054136

5.

Bruton tyrosine kinase inhibitors for the treatment of mantle cell lymphoma: review of current evidence and future directions.

Bond, David A; Alinari, Lapo; Maddocks, Kami.

Clin Adv Hematol Oncol ; 17(4): 223-233, 2019 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-31188814

6.

How I treat relapsed classical Hodgkin lymphoma after autologous stem cell transplant.

Alinari, Lapo; Blum, Kristie A.

Blood ; 127(3): 287-95, 2016 Jan 21.

Artículo en Inglés | MEDLINE | ID: mdl-26576863

7.

Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformation.

Alinari, Lapo; Mahasenan, Kiran V; Yan, Fengting; Karkhanis, Vrajesh; Chung, Ji-Hyun; Smith, Emily M; Quinion, Carl; Smith, Porsha L; Kim, Lisa; Patton, John T; Lapalombella, Rosa; Yu, Bo; Wu, Yun; Roy, Satavisha; De Leo, Alessandra; Pileri, Stefano; Agostinelli, Claudio; Ayers, Leona; Bradner, James E; Chen-Kiang, Selina; Elemento, Olivier; Motiwala, Tasneem; Majumder, Sarmila; Byrd, John C; Jacob, Samson; Sif, Said; Li, Chenglong; Baiocchi, Robert A.

Blood ; 125(16): 2530-43, 2015 Apr 16.

Artículo en Inglés | MEDLINE | ID: mdl-25742700

8.

Pembrolizumab in classical Hodgkin's lymphoma.

Maly, Joseph; Alinari, Lapo.

Eur J Haematol ; 97(3): 219-27, 2016 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-27147112

9.

De novo CD5+ diffuse large B-cell lymphoma: Adverse outcomes with and without stem cell transplantation in a large, multicenter, rituximab treated cohort.

Alinari, Lapo; Gru, Alejandro; Quinion, Carl; Huang, Ying; Lozanski, Arletta; Lozanski, Gerard; Poston, Jacqueline; Venkataraman, Girish; Oak, Eunhye; Kreisel, Friederike; Park, Steven I; Matthews, Stephanie; Abramson, Jeremy S; Iris Lim, Hana; Martin, Peter; Cohen, Jonathon B; Evens, Andrew; Al-Mansour, Zeina; Singavi, Arun; Fenske, Timothy S; Blum, Kristie A.

Am J Hematol ; 91(4): 395-9, 2016 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-26800311

10.

Awakening exhausted NK cells in lymphomas.

Alinari, Lapo.

Blood ; 131(16): 1768-1769, 2018 04 19.

Artículo en Inglés | MEDLINE | ID: mdl-29674350

11.

Toward autophagy-targeted therapy in lymphoma.

Alinari, Lapo.

Blood ; 129(13): 1740-1742, 2017 03 30.

Artículo en Inglés | MEDLINE | ID: mdl-28360356

12.

Inhibition of SRC-3 as a potential therapeutic strategy for aggressive mantle cell lymphoma.

Bijou, Imani; Liu, Yang; Lu, Dong; Chen, Jianwei; Sloan, Shelby; Alinari, Lapo; Lonard, David M; O'Malley, Bert W; Wang, Michael; Wang, Jin.

PLoS One ; 19(4): e0289902, 2024.

Artículo en Inglés | MEDLINE | ID: mdl-38683834

13.

Resistance to PRMT5-targeted therapy in mantle cell lymphoma.

Long, Mackenzie Elizabeth; Koirala, Shirsha; Sloan, Shelby; Brown-Burke, Fiona; Weigel, Christoph; Villagomez, Lynda; Corps, Kara; Sharma, Archisha; Hout, Ian; Harper, Margaret; Helmig-Mason, JoBeth; Tallada, Sheetal; Chen, Zhengming; Scherle, Peggy; Vaddi, Kris; Chen-Kiang, Selina; Di Liberto, Maurizio; Meydan, Cem; Foox, Jonathan; Butler, Daniel; Mason, Christopher; Alinari, Lapo; Blaser, Bradley W; Baiocchi, Robert.

Blood Adv ; 8(1): 150-163, 2024 01 09.

Artículo en Inglés | MEDLINE | ID: mdl-37782774

14.

Post-infusion PD-1+CD8+CAR-T cells identify patients responsive to CD19-CAR-T therapy in non-Hodgkin's lymphoma.

Denlinger, Nathan; Song, No-Joon; Zhang, Xiaoli; Jeon, Hyeongseon; Peterson, Chelsea; Wang, Yi; Reynolds, Kelsi; Bolz, Robert; Miao, Jessica; Song, Chunhua; Wu, Dayong; Chan, Wing Keung; Bezerra, Evandro D; Epperla, Narendranath; Voorhees, Timothy J; Brammer, Jonathan E; Kittai, Adam S; Bond, David A; Sawalha, Yazeed; Sigmund, Audrey M; Reneau, John C; Rubinstein, Mark P; Hanel, Walter; Christian, Beth; Baiocchi, Robert A; Maddocks, Kami J; Alinari, Lapo; Vasu, Sumithira; de Lima, Marcos; Chung, Dongjun; Jaglowski, Samantha M; Li, Zihai; Huang, Xiaopei; Yang, Yiping.

Blood Adv ; 2024 Mar 23.

Artículo en Inglés | MEDLINE | ID: mdl-38607381

15.

Combination anti-CD74 (milatuzumab) and anti-CD20 (rituximab) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphoma.

Alinari, Lapo; Yu, Bo; Christian, Beth A; Yan, Fengting; Shin, Jungook; Lapalombella, Rosa; Hertlein, Erin; Lustberg, Mark E; Quinion, Carl; Zhang, Xiaoli; Lozanski, Gerard; Muthusamy, Natarajan; Prætorius-Ibba, Mette; O'Connor, Owen A; Goldenberg, David M; Byrd, John C; Blum, Kristie A; Baiocchi, Robert A.

Blood ; 117(17): 4530-41, 2011 Apr 28.

Artículo en Inglés | MEDLINE | ID: mdl-21228331

16.

FTY720 increases CD74 expression and sensitizes mantle cell lymphoma cells to milatuzumab-mediated cell death.

Alinari, Lapo; Mahoney, Emilia; Patton, John; Zhang, Xiaoli; Huynh, Lenguyen; Earl, Christian T; Mani, Rajeswaran; Mao, Yicheng; Yu, Bo; Quinion, Carl; Towns, William H; Chen, Ching-Shih; Goldenberg, David M; Blum, Kristie A; Byrd, John C; Muthusamy, Natarajan; Praetorius-Ibba, Mette; Baiocchi, Robert A.

Blood ; 118(26): 6893-903, 2011 Dec 22.

Artículo en Inglés | MEDLINE | ID: mdl-22042694

17.

Inhibition of SRC-3 as a potential therapeutic strategy for aggressive mantle cell lymphoma.

Bijou, Imani; Liu, Yang; Lu, Dong; Chen, Jianwei; Sloan, Shelby; Alinari, Lapo; Lonard, David M; O'Malley, Bert W; Wang, Michael; Wang, Jin.

Res Sq ; 2023 Mar 10.

Artículo en Inglés | MEDLINE | ID: mdl-36945511

18.

T Cell-intrinsic Immunomodulatory Effects of TAK-981 (Subasumstat), a SUMO-activating Enzyme Inhibitor, in Chronic Lymphocytic Leukemia.

Lam, Vi; Roleder, Carly; Liu, Tingting; Bruss, Nur; Best, Scott; Wang, Xiaoguang; Phillips, Tycel; Shouse, Geoffrey; Berger, Allison J; Alinari, Lapo; Wang, Lili; Siddiqi, Tanya; Pennock, Nathan D; Danilov, Alexey V.

Mol Cancer Ther ; 22(9): 1040-1051, 2023 09 05.

Artículo en Inglés | MEDLINE | ID: mdl-37420267

19.

Impact of circulating lymphoma cells at diagnosis on outcomes in patients with Waldenstrom macroglobulinemia.

Nalin, Ansel; Zhao, Qiuhong; Voorhees, Timothy; Bond, David; Sawalha, Yazeed; Hanel, Walter; Sigmund, Audrey; Annunzio, Kaitlin; Alinari, Lapo; Baiocchi, Robert; Maddocks, Kami; Jones, Dan; Christian, Beth; Epperla, Narendranath.

Front Oncol ; 13: 1264387, 2023.

Artículo en Inglés | MEDLINE | ID: mdl-37781209

20.

Outcomes associated with allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma in the era of novel agents.

Faisal, Muhammad Salman; Hanel, Walter; Voorhees, Timothy; Li, Rui; Huang, Ying; Khan, Abdullah; Bond, David; Sawalha, Yazeed; Reneau, John; Alinari, Lapo; Baiocchi, Robert; Christian, Beth; Maddocks, Kami; Efebera, Yvonne; Penza, Sam; Saad, Ayman; Brammer, Jonathan; DeLima, Marcos; Jaglowski, Samantha; Epperla, Narendranath.

Cancer Med ; 12(7): 8228-8237, 2023 04.

Artículo en Inglés | MEDLINE | ID: mdl-36653918

Portal de Búsqueda de la BVS Ecuador

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

PRMT5 supports multiple oncogenic pathways in mantle cell lymphoma.

Prognostic relevance of circulating lymphoma cells at diagnosis in newly diagnosed follicular lymphoma patients.

Protein arginine methyltransferase 5 represses tumor suppressor miRNAs that down-regulate CYCLIN D1 and c-MYC expression in aggressive B-cell lymphoma.

Transducin ß-like protein 1 controls multiple oncogenic networks in diffuse large B-cell lymphoma.

Bruton tyrosine kinase inhibitors for the treatment of mantle cell lymphoma: review of current evidence and future directions.

How I treat relapsed classical Hodgkin lymphoma after autologous stem cell transplant.

Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformation.

Pembrolizumab in classical Hodgkin's lymphoma.

De novo CD5+ diffuse large B-cell lymphoma: Adverse outcomes with and without stem cell transplantation in a large, multicenter, rituximab treated cohort.

Awakening exhausted NK cells in lymphomas.

Toward autophagy-targeted therapy in lymphoma.

Inhibition of SRC-3 as a potential therapeutic strategy for aggressive mantle cell lymphoma.

Resistance to PRMT5-targeted therapy in mantle cell lymphoma.

Post-infusion PD-1+CD8+CAR-T cells identify patients responsive to CD19-CAR-T therapy in non-Hodgkin's lymphoma.

Combination anti-CD74 (milatuzumab) and anti-CD20 (rituximab) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphoma.

FTY720 increases CD74 expression and sensitizes mantle cell lymphoma cells to milatuzumab-mediated cell death.

Inhibition of SRC-3 as a potential therapeutic strategy for aggressive mantle cell lymphoma.

T Cell-intrinsic Immunomodulatory Effects of TAK-981 (Subasumstat), a SUMO-activating Enzyme Inhibitor, in Chronic Lymphocytic Leukemia.

Impact of circulating lymphoma cells at diagnosis on outcomes in patients with Waldenstrom macroglobulinemia.

Outcomes associated with allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma in the era of novel agents.